Skip to content

New Clinical Trial Starting Called ELMWOOD


A new clinical trial is opening in the UK

ELMWOOD is investigating a drug called 'Elafibranor'. It is an investigational drug that is taken by mouth. It activates specific receptors (PPARα/δ) in the human body, particularly in the liver1,2. Activation of these receptors is thought to have different effects, including reduced inflammation and improvement of bile acid composition and flow3.

The ELMWOOD study is a Phase 2 trial. For more information about different types of clinical trial, what's usually involved, and questions to ask, download or order our free Guide to PSC Clinical Trials.